Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 9 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Composés actifs
Mécanisme d'action
Preuves cliniques
Flower essential oil exhibited potent antinociceptive activity, reducing acetic acid-induced writhing by 73.88 ± 2.78% and increasing pain withdrawal latency in mice [PMID:36960955].
Flower essential oil demonstrated a potent wound healing effect, achieving 98.08 ± 1.37% wound closure by the 12th day of treatment in a model study [PMID:36960955].
Essential oils and their nanoemulsions showed high larvicidal activity, with nanoemulsions achieving a lower LC50 (88.30 ppm) compared to bulk oil (247.72 ppm) against Culex pipiens [PMID:37960039, PMID:30632272].
Synthèse des preuves
Sources PubMed
- 1.PMID: 30812224 (2004) — First Report of Powdery Mildew Caused by Oidium Subgenus Pseudoidium on Lonicera caprifolium in Italy. · Plant disease
- 2.PMID: 36960955 (2024) — Chemical composition and biological activities of Lonicera caprifolium L. (Caprifoliaceae) essential oil. · Natural product research
- 3.PMID: 37960039 (2023) — Sustainable Pest Management Using Novel Nanoemulsions of Honeysuckle and Patchouli Essential Oils against the West Nile Virus Vector, Culex pipiens, under Laboratory and Field Conditions. · Plants (Basel, Switzerland)
- 4.PMID: 38907660 (2025) — Volatile oil constituents, antioxidant and antibacterial activities of Lonicera caprifolium L. in different areas of Iran. · Natural product research
- 5.PMID: 30632272